News

G S Krishnan takes over as new ABLE President

Bengaluru, 01 April 2021: Mr G S Krishnan, formerly regional president & MD, Novozymes South Asia Pvt Ltd, a Danish biotech company, has taken charge as the new President of India’s leading biotechnology industry organization, the Association of Biotechnology-Led Enterprises(ABLE). Dr Kiran Mazumdar-Shaw, will continue as the association’s honorary non-executive chairperson.

Mr Krishnan, will head a 9-member executive council that was elected for a three-year term starting on April 1, 2021, last January.  The other office bearers are Dr Anand Anandkumar of Bugworks Research as Vice President & Treasurer, and Mr Ravi Bhola of K&S Partners will be the new General Secretary of ABLE.

Aiming to further catalyze the growth of India’s $ 70 billion BioEconomy, the Association has also set up an ABLE Business Council, that will be chaired by former ABLE President and founder of biotech startup Jananom, Dr P M Murali. The ABLE Business Council will comprise of all the past presidents of ABLE such as Dr Kiran Mazumdar-Shaw, Dr K K Narayanan, Dr Vijay Chandru and Mr Shrikumar Suryanarayan.

“ India’s BioPharmaceutical segment has played a commendable role in the discovery and manufacturing of COVID-19 vaccine during the pandemic and we need to build on this great momentum and lead the world in playing a critical role, identifying our capabilities,” said Mr Krishnan while taking over as the new ABLE President for 2021-24.

 Mr Krishnan added that opportunities in the BioIndustrial and BioAgriculture are also highly promising and require a conducive regulatory framework. The 4,300+ Biotech startups too will contribute significantly for the growth of the biotech  industry and requires all the support to grab near to market opportunities. 

“ It will be my endeavor to focus on these opportunities working together with the ABLE team and all the relevant stakeholders in making India a $150 billion Bio-based Economy by the year 2025,” the ABLE President said.

The outgoing ABLE president chairman of Sea6Energy, Mr Shrikumar Suryanarayan noted: " Our biotech industry demonstrated its power to heal the world during the ongoing COVID-19 pandemic by providing super quick diagnostic solutions and compressing the development time to roll out vaccines against the SARS CoV-2 virus within a year and we are proud that two of our members companies have been at the forefront of providing vaccines to not just India but the world. i am sure the biotech industry will be at the service of humanity for many more centuries to come."

The other elected members of the ABLE Executive Council (2021-24) are: Dr Kavitha Iyer Rodrigues ( Zumutor Biologics), Dr Ezhil Subbian ( StringBio), Dr Shama Bhat ( Bhat Biotech), Dr Shriram Ragavan( Jananom) and Mr Venkat K Bundla( Garphi Biosciences).

Founded in 2003, ABLE ( www.ableindia.in) represents more than 400 companies in the country’s biotech ecosystem.                                                            

********

For more information, please contact Mr Narayanan Suresh, chief operating officer, ABLE @ 98455 18573 or coo@ableindia.org.in

“ India’s BioPharmaceutical segment has played a commendable role in the discovery and manufacturing of COVID-19 vaccine during the pandemic and we need to build on this great momentum and lead the world in playing a critical role, identifying our capabilities,” said Mr Krishnan while taking over as the new ABLE President for 2021-24.

Recommended News

Archives